APOA1 and Alzheimer disease: Conversely, HDL-C has been found to be reduced in AD subjects who have vascular risk factors[172], and plasma apoA-I has been reported to be reduced in AD patients[173] and negatively associates with cognitive decline independent of Aβ, indicating a protective homeostatic role for apoA-I against cognitive decline in the elderly[174].